It is called "Cattolica TJU Research" and is a benefit company that will promote scientific research in the neuroscience field.
The result of an agreement signed at the
Agostino Gemelli Irccs University Hospital
by the Rector of the Catholic University Franco Anelli and by the Chief Operating Officer of
Thomas Jefferson University
Kathy Gallagher, it also provides for the construction of the
Brain Center
"Vickie and Jack Farber Institute for Neuroscienceat Policlinico Gemelli in Rome ", whose project started with the symbolic laying of the first stone yesterday afternoon at Gemelli.
The new company will offer scientific advice for the use of new clinical equipment, particularly in the neuroscience sector, focusing on the development of new technologies based on the acquisition and processing of neurophysiological data in humans and animals.
From the design and implementation of software that can process electrophysiological data in the neuroscience sector to research activities regarding new protocols, including basic and applicative studies, "Cattolica TJU Research" will collaborate with universities, organizations and institutions for the development of new lines of Research.
The Brain Center "Vickie and Jack Farber Institute for Neuroscience at Policlinico Gemelli", 'twin' of the one already built in Philadelphia, will allow the carrying out of translational and clinical research on the most important diseases of neuropsychiatric interest, as well as cutting-edge treatments of various pathologies , with particular reference to brain tumors, thanks to the donation by the guests of honor Ellen Farber and Bill Farber, financiers, of a
Cyberknife
, a leading tool in the radiotherapy sector.
The Thomas Jefferson University delegation was formed, among others, by Mark Tykocinski, President TJU, Ignazio Marino, Executive Vice President for Jefferson International Innovative Strategic Ventures TJU, Robert Rosenwasser, Professor of Neurosurgery and President "Vickie and Jack Farber Institute for Neuroscience ".
Those of the Catholic University and the Gemelli Irccs Polyclinic by Marco Elefanti, General Director of the Gemelli Polyclinic, Paolo Nusiner, General Director of the Catholic University.